Multidisciplinary care and management of very low-risk prostate cancer

被引：0
|
作者：
Aizer, Ayal A.
Paly, Jonathan J.
Zietman, Anthony L.
Paul Linh Nguyen
Beard, Clair
Rao, Sandhya K.
Kaplan, Irving D.
Niemierko, Andrzej
Hirsch, Michelle S.
Wu, Chin-Lee
Olumi, Aria F.
Michaelson, M. Dror
D'Amico, Anthony Victor
Efstathiou, Jason Alexander
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Sch Med, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[6] Brigham & Womens Hosp, Boston, MA 02115 USA
[7] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.55
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
55
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Overactive Surveillance: Is "Conservative" Management for Low-risk Prostate Cancer Too Aggressive?
    Loeb, Stacy
    [J]. EUROPEAN UROLOGY, 2019, 76 (04) : 467 - 468
  • [42] Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer
    Aizer, Ayal A.
    Chen, Ming-Hui
    Hattangadi, Jona
    D'Amico, Anthony V.
    [J]. BJU INTERNATIONAL, 2014, 113 (01) : 43 - 50
  • [43] VARIATION IN GUIDELINE-CONCORDANT CONSERVATIVE MANAGEMENT FOR LOW-RISK PROSTATE CANCER
    Loeb, Stacy
    Walter, Dawn
    Byrne, Nataliya
    Makarov, Danil
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E632 - E632
  • [44] Referral to a Multidisciplinary Genitourinary Oncology Clinic Increases Rates of Active Surveillance in Low-risk Prostate Cancer
    Aizer, A. A.
    Paly, J. J.
    Zietman, A. L.
    Nguyen, P. L.
    Beard, C. J.
    Rao, S. K.
    Kaplan, I. D.
    Hirsch, M. S.
    Wu, C.
    Efstathiou, J. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S101 - S102
  • [45] Outcomes of serial MRI/ultrasound fusion targeted biopsy in men with very low-risk and low-risk prostate cancer managed with active surveillance.
    Hsiang, Walter
    Ghabili, Kamyar
    Syed, Jamil
    Nguyen, Kevin
    Suarez-Sarmiento, Alfredo
    Leapman, Michael
    Sprenkle, Preston
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [46] Active Surveillance for Low-Risk Prostate Cancer-An Evolving International Standard of Care
    Cooperberg, Matthew R.
    [J]. JAMA ONCOLOGY, 2017, 3 (10) : 1398 - 1399
  • [47] What is the molecular pathology of low-risk prostate cancer?
    Hemamali Samaratunga
    Jonathan I. Epstein
    [J]. World Journal of Urology, 2008, 26 : 431 - 436
  • [48] Racial Disparities in Low-Risk Prostate Cancer Reply
    Mahal, Brandon A.
    Huang, Franklin W.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (17): : 1727 - 1728
  • [49] mTOR inhibitors for treatment of low-risk prostate cancer
    Liss, Michael A.
    Rickborn, Lanette
    DiGiovanni, John
    Bacich, Dean
    DeGraffenried, Linda A.
    Parihar, Manish
    Thompson, Ian M.
    Sharp, Zelton Dave
    [J]. MEDICAL HYPOTHESES, 2018, 117 : 63 - 68
  • [50] Active surveillance preferred for low-risk prostate cancer
    Bagcchi, Sanjeet
    [J]. LANCET ONCOLOGY, 2015, 16 (08): : E384 - E384
12345